Company profile · free preview
Akanda Corp.
AKAN · NASDAQ · Healthcare · Updated 11/16/2026
Five-year financials
| Fiscal year |
|---|
| Revenue |
| Net income |
| Diluted EPS |
| Operating cash flow |
| Free cash flow |
| Cash |
| Total debt |
Financials are being prepared.
Want the story behind these numbers? Ask Osiris anything about Akanda Corp.'s filings — free.
Create free accountAkanda Corp. return on capital (fiscal 2025)
ROIC
—
Return on capital
—
Return on equity
—
Return on assets
-647.1%
Gross margin
-60.5%
Operating margin
-1931.0%
Net debt / EBITDA
-2.93x
SEC filings
- F-1/A2026-10-19EDGAR
Ask anything about Akanda Corp.'s filings
"What changed since last year?" "Where is the cash going?" Get answers drawn straight from the filings.
Start researching freeCompare AKAN head-to-head
More Healthcare companies
Ascentage Pharma Group International AAPGAbbVie ABBVAmerisourceBergen Corporation ABCAbCellera Biologics Inc. ABCLAbbott Laboratories ABTArbutus Biopharma Corp ABUSAmgen AMGNBaxter International Inc. BAXBecton, Dickinson and Company BDXBioStem Technologies, Inc. BSEMConcentra CONCVS Health Corp. CVS